BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 45 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $220,000 | -62.7% | 887,228 | -22.2% | 0.00% | – |
| Q2 2022 | $590,000 | -77.7% | 1,140,870 | -11.5% | 0.00% | – |
| Q1 2022 | $2,642,000 | -51.7% | 1,288,991 | -1.6% | 0.00% | – |
| Q4 2021 | $5,465,000 | +8.1% | 1,310,490 | +141.0% | 0.00% | – |
| Q3 2021 | $5,057,000 | -31.4% | 543,839 | +32.9% | 0.00% | – |
| Q2 2021 | $7,368,000 | – | 409,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |